United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
1996_register
executive
2010-09-24
article
Current Good Manufacturing Practices for Blood and Blood Components: Notification of Consignees Receiving Blood and Blood Components at Increased Risk for Transmitting HIV Infection; Correction of Effective Date
Rules and Regulations
D09002ee1be028db3
D09002ee1be028e58
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administation
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is correcting a final rule on current good manufacturing practices for blood and blood components, that appeared in the Federal Register of September 9, 1996 (61 FR 47413). The document was published with an incorrect effective date. The effective date had been inadvertently switched with the comment deadline for the information collection requirements. This document corrects those errors.
61 FR 66919
https://www.govinfo.gov/app/details/FR-1996-12-19/96-32271
96-32271
fr19de96-25
RIN 0910-AA05
4160-01-F
Docket No. 91N-0152
https://www.govinfo.gov/app/details/FR-1996-12-19/96-32271
https://www.govinfo.gov/content/pkg/FR-1996-12-19/html/96-32271.htm
https://www.govinfo.gov/content/pkg/FR-1996-12-19/pdf/96-32271.pdf
1 p.
66919
66919
61 FR 66919
Code of Federal Regulations
Title 21 Part 606
21 CFR Part 606
Code of Federal Regulations
Title 21 Part 610
21 CFR Part 610
Regulation Identification Number 0910-AA05
RIN 0910-AA05
Current Good Manufacturing Practices for Blood and Blood Components: Notification of Consignees Receiving Blood and Blood Components at Increased Risk for Transmitting HIV Infection; Correction of Effective Date; Federal Register Vol. 61, Issue
RULE
96-32271
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administation
1996-09-09
1996-11-08
Docket No. 91N-0152
4160-01-F
96-32271
Final rule; correction of effective date.
The Food and Drug Administration (FDA) is correcting a final rule on current good manufacturing practices for blood and blood components, that appeared in the Federal Register of September 9, 1996 (61 FR 47413). The document was published with an incorrect effective date. The effective date had been inadvertently switched with the comment deadline for the information collection requirements. This document corrects those errors.
Effective September 9, 1996, the effective date of the regulation published at 61 FR 47413 is corrected to February 7, 1997. The deadline for written comments on the information collection requirements of the final rule published at 61 FR 47413 is corrected to November 8, 1996.
Sharon Carayiannis, Center for Biologics Evaluation and Research (HFM-630), Food and Drug Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852- 1448, 301-594-3074.
Federal Register
Vol. 61, no. 245
Office of the Federal Register, National Archives and Records Administration
1996-12-19
continuing
daily
deposited
born digital
322 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-1996-12-19
P0b002ee180a2a43f
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr19de96
https://www.govinfo.gov/app/details/FR-1996-12-19
https://www.govinfo.gov/content/pkg/FR-1996-12-19/pdf/FR-1996-12-19.pdf
fdlp
66867
67178
DGPO
2010-09-24
2023-05-06
FR-1996-12-19
machine generated
eng
FR
FR-1996-12-19
61
245